DRUG DISCOVERY CONSULTANTS LIMITEDActive
Key figures
Like most small UK companies, DRUG DISCOVERY CONSULTANTS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2025/26Balance sheet structure
Filed accounts2021/22–2025/26
| 2021/22 | 2022/23 | 2023/24 | 2024/25 | 2025/26 | |
|---|---|---|---|---|---|
| Total assets | 6,600 | 13,155 | 9,742 | 9,394 | 9,394 |
| Total liabilities | 1,438 | 3,341 | 250 | 200 | 200 |
| Net assets / total equity | 5,162 | 9,814 | 9,492 | 9,194 | 9,194 |
| Average number of employees | 2 | 2 | 2 | 2 | 2 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: DRUG DISCOVERY CONSULTANTS LIMITED
Company
DRUG DISCOVERY CONSULTANTS LIMITED is a private limited company registered with Companies House under company number 13199717. It was incorporated on 12 Feb 2021. Its status is active. The registered office is in Stockport (SK2). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2025/26 (period ending 31 Jan 2026); the company files micro-entity accounts. Net assets were £9,194, up 0% on the previous year. Total assets were £9,394 and total liabilities £200. The company had an average of 2 employees. Figures are available for 5 financial years (2021/22–2025/26).
Control and charges
2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 31 Oct 2027. The next confirmation statement is due by 25 Feb 2027.